OP134 Pan-Canadian Oncology Drug Review Decisions And Access To Anticancer Treatments In Canada
Introduction: The Canadian Agency for Drugs and Technologies in Health (CADTH) pan-Canadian Oncology Drug Review (pCODR) plays an important role in public reimbursement decision-making for oncology drugs in Canada. This research studies the relation of positive pCODR decisions to new cancer treatmen...
Published in: | International Journal of Technology Assessment in Health Care |
---|---|
Main Authors: | , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Cambridge University Press (CUP)
2018
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1017/s0266462318001526 https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0266462318001526 |